Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Launches Microarray Services, Aligns with Agilent

NEW YORK, March 26 - Paradigm Genetics of Research Triangle Park, NC, today tossed its hat into the microarray processing business, aligning itself with the Agilent Technologies platform with the announcement of a co-marketing agreement with the No. 2 manufacturer of microarrays.


Under the agreement, Paradigm will be a preferred service provider for Agilent's microarray products. The agreement is in addition to a multi-year supply deal already in place with Agilent to service Paradigm's five-year $23.8 million toxicogenomics contract with the National Institute of Environmental Health Sciences, a deal that calls for the processing of thousands of DNA microarrays.


Paradigm, which trades on the Nasdaq exchange, restructured in April, laying off 20 percent of its workforce and replaced founder and CEO John Ryals with former Syngenta executive Heinrich Gugger.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.